The phrase "a more cost effectiveness" is not correct in English.
Did you mean "more cost-effective"? You can use "more cost-effective" when comparing the efficiency of different options in terms of cost.
Example: "After analyzing the budget, we found that switching suppliers would be a more cost-effective solution for our project."
Alternatives: "greater cost efficiency" or "better cost-effectiveness."
The C-AKIC was able to demonstrate a more cost-effectiveness, efficiency, and safe of model of clinical care.
A lower value for the incremental cost effectiveness ratio indicates a more cost effective intervention.
"Doing it literally one right after another isn't how we normally do this," said Dr. Forstner, who is urging more cooperation between universities to get the research done with more cost effectiveness.
The private sector model for higher education also suggests that colleges and universities can achieve more cost effectiveness through class size increases.
These efforts to improve quality can be seen as a response to demands for more cost-effectiveness and better medical results.
The lower the incremental cost effectiveness ratio, the more cost effective a technology [ 5].
What is more, cost-effectiveness analysis studies of daptomycin, vancomycin and linezolid for MRSA-related cSSTIs found that daptomycin and linezolid were potentially more cost effective than vancomycin; however, daptomycin had no advantage when compared with linezolid.
Ultrathin crystalline silicon solar cells are alternative technology roadmap to achieve more cost-effectiveness.
The progress of WSNs have been associated with the innovation of sensor nodes with the more significant features of smaller size, more cost-effectiveness, lower latency and powerful antenna coverage.
Among those surveyed, 79percentt favor more comparative effectiveness research; 80percentt support more cost-effectiveness data, although only 42percentt feel well prepared to interpret it.
Other conditions associated with a more favorable cost-effectiveness ratio included a low discount rate, longer delay to re-presentation by patients with undiagnosed active TB, high prevalence of smear-negative TB among TB suspects, and high rate of treatment based on positive cultures (Figure 2).
